174 related articles for article (PubMed ID: 34974181)
21. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP
Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
[TBL] [Abstract][Full Text] [Related]
22. Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis.
Cappelli F; Baldasseroni S; Bergesio F; Perlini S; Salinaro F; Padeletti L; Attanà P; Paoletti Perini A; Moggi Pignone A; Grifoni E; Fabbri A; Marchionni N; Gensini GF; Perfetto F
Clin Cardiol; 2015 Feb; 38(2):69-75. PubMed ID: 25645201
[TBL] [Abstract][Full Text] [Related]
23. Restrictive cardiac phenotype as primary cause of impaired aerobic capacity in Afro-Caribbean patients with val122ile variant transthyretin amyloid cardiomyopathy.
Monfort A; Banydeen R; Demoniere F; Courty B; Codiat R; Neviere R; Inamo J
Amyloid; 2020 Sep; 27(3):145-152. PubMed ID: 32024385
[No Abstract] [Full Text] [Related]
24. The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients.
Dungu J; Sattianayagam PT; Whelan CJ; Gibbs SD; Pinney JH; Banypersad SM; Rowczenio D; Gilbertson JA; Lachmann HJ; Wechalekar A; Gillmore JD; Hawkins PN; Anderson LJ
Am Heart J; 2012 Jul; 164(1):72-9. PubMed ID: 22795285
[TBL] [Abstract][Full Text] [Related]
25. Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis.
Damy T; Judge DP; Kristen AV; Berthet K; Li H; Aarts J
J Cardiovasc Transl Res; 2015 Mar; 8(2):117-27. PubMed ID: 25743445
[TBL] [Abstract][Full Text] [Related]
26. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
27. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
[TBL] [Abstract][Full Text] [Related]
28. Transthyretin amyloid cardiomyopathy.
Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
[TBL] [Abstract][Full Text] [Related]
29. Transthyretin Glu54Leu - an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type.
Hellman U; Lång K; Ihse E; Jonasson J; Olsson M; Lundgren HE; Pilebro B; Westermark P; Wixner J; Anan I
Scand J Clin Lab Invest; 2019 Oct; 79(6):372-376. PubMed ID: 31169435
[TBL] [Abstract][Full Text] [Related]
30. ATTR Epidemiology, Genetics, and Prognostic Factors.
Obi CA; Mostertz WC; Griffin JM; Judge DP
Methodist Debakey Cardiovasc J; 2022; 18(2):17-26. PubMed ID: 35414855
[TBL] [Abstract][Full Text] [Related]
31. Sex differences in transthyretin cardiac amyloidosis.
Aimo A; Panichella G; Garofalo M; Gasparini S; Arzilli C; Castiglione V; Vergaro G; Emdin M; Maffei S
Heart Fail Rev; 2024 Mar; 29(2):321-330. PubMed ID: 37566193
[TBL] [Abstract][Full Text] [Related]
32. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation.
Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M
J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309
[TBL] [Abstract][Full Text] [Related]
33. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
Coelho T; Maurer MS; Suhr OB
Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
[TBL] [Abstract][Full Text] [Related]
34. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
Ruberg FL; Maurer MS; Judge DP; Zeldenrust S; Skinner M; Kim AY; Falk RH; Cheung KN; Patel AR; Pano A; Packman J; Grogan DR
Am Heart J; 2012 Aug; 164(2):222-228.e1. PubMed ID: 22877808
[TBL] [Abstract][Full Text] [Related]
35. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
Paton DM
Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
[TBL] [Abstract][Full Text] [Related]
36. Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis.
Ioannou A; Porcari A; Patel RK; Razvi Y; Sinigiani G; Martinez-Naharro A; Venneri L; Moon J; Rauf MU; Lachmann H; Wechelakar A; Hawkins PN; Gillmore JD; Fontana M
Circ Cardiovasc Imaging; 2023 Jul; 16(7):523-535. PubMed ID: 37431665
[TBL] [Abstract][Full Text] [Related]
37. Early Detection of Cardiac Amyloidosis in Transthyretin Mutation Carriers.
Nagano N; Muranaka A; Nishikawa R; Ohwada W; Kouzu H; Kamiyama N; Fujito T; Mochizuki A; Nagahara D; Nakanishi M; Ohkubo Y; Hisahara S; Nakao S; Katoh N; Ishikawa A; Sakurai A; Yano T
Int Heart J; 2022; 63(1):168-175. PubMed ID: 35095067
[TBL] [Abstract][Full Text] [Related]
38. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
39. Cardiac Amyloidosis in a Child Presenting with Syncope: The First Reported Case and a Diagnostic Dilemma.
Torpoco Rivera DM; Williams CT; Karpawich PP
Pediatr Cardiol; 2022 Mar; 43(3):700-703. PubMed ID: 34783874
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta-analysis.
Antonopoulos AS; Panagiotopoulos I; Kouroutzoglou A; Koutsis G; Toskas P; Lazaros G; Toutouzas K; Tousoulis D; Tsioufis K; Vlachopoulos C
Eur J Heart Fail; 2022 Sep; 24(9):1677-1696. PubMed ID: 35730461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
